Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Wegener's Granulomatosis With Cyclophosphamide
This study has been completed.
Study NCT00001155   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vasculitis
Wegener's Granulomatosis
Additional conditions recognized in this trial
Wegener Granulomatosis
More general conditions related to this trial
Cardiovascular Diseases
Kidney Diseases
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
cyclophosphamide
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services